The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
July 19th 2025
Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action.
ASHP to Create Pharmacy Technician Forum
October 3rd 2017On September 29, 2017, the ASHP (American Society of Health-System Pharmacists) Board of Directors voted unanimously to approve the creation of an enhanced membership home for pharmacy technicians — the ASHP Pharmacy Technician Forum.
Read More
Merck Discontinues 2 HCV Clinical Programs
September 30th 2017This decision was made based on a review of available phase 2 efficacy data and in consideration of the evolving marketplace and the growing number of treatment options available for patients with chronic HCV infection, including elbasvir and grazoprevir (Zepatier).
Read More
New Search Tool Enables Better Access to Adverse Drug Reaction Information
September 29th 2017While the FAERS dashboard now offers stakeholders many more ways of searching for and organizing data on adverse events reported to the FDA for many drug and biologic products, there remain limitations to the data.
Read More
Study Finds Medicare 'DIR Fee' Legislation Would Save Government Billions
September 29th 2017Eliminating retroactive pharmacy payment reductions — or post point-of-sale pharmacy "DIR fees" — in Medicare Part D would save the federal government $3.4 billion over 10 years, according to a Wakely Consulting Group study released today by the National Community Pharmacists Association.
Read More
FDA Approves Continuous Glucose Monitoring System for Diabetes
September 28th 2017Officials with the FDA have approved FreeStyle Libre Flash Glucose Monitoring System (Abbot Diabetes Care Inc.), the first continuous glucose monitoring system for adult patients that reduces the need for fingerstick testing.
Read More
Beauty Product Manufacturer to Cease Distribution of Unapproved Drugs
September 27th 2017A New Jersey company that sold injectable skin whitening and other beauty products has been ordered to stop selling and recall some of its products because they are unapproved new drugs that are potentially unsafe to consumers, according to the FDA's press release.
Read More